| KROMEYA FRESENIUS KABI DEUTSCHLAND GMBH
1764560 22 Jan 2016 | on 08 Jul 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use, for the treatment of neurological and neuromuscular diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, seizure disorders, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, pharmaceutical preparations for human use for the treatment of immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndromes, pharmaceutical preparations for human use for the treatment of inflammatory diseases and disorders, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, oncological diseases and disorders and anti-viral agents. | |